Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Baxter
Dow
Merck
AstraZeneca
Teva
Mallinckrodt
Boehringer Ingelheim
Covington
Fish and Richardson

Generated: May 21, 2018

DrugPatentWatch Database Preview

Details for Patent: 5,459,163

« Back to Dashboard

Summary for Patent: 5,459,163
Title: Medicament to combat autoimmune diseases
Abstract:A pharmaceutical composition for use in the treatment of chronic Graft-versus-host diseases as well as autoimmune diseases, in particular for the treatment of systemic lupus erythematosus containing as an active ingredient at least one compound of the formulae 1 or 2 ##STR1## the latter being present per se or in the form of a physiologically tolerable salt. The invention also relates to a dosage unit form of said pharmaceutical composition and a method of treating chronic Graft-versus host diseases as well as autoimmune diseases, in particular systemic lupus erythematosus.
Inventor(s): Bartlett; Robert R. (Darmstadt, DE), Schleyerbach; Rudolph (Hofheim am Taunus, DE), Kammerer; Friedrich-Johannes (Hochheim am Main, DE)
Assignee: Hoechst Aktiengesellschaft (Frankfurt, DE)
Application Number:08/119,840
Patent Claim Types:
see list of patent claims
Composition; Compound;

Drugs Protected by US Patent 5,459,163

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Foreign Priority and PCT Information for Patent: 5,459,163

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
Germany35 34 440.7Sep 27, 1985

International Family Members for US Patent 5,459,163

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria 122033 ➤ Try a Free Trial
Austria 96669 ➤ Try a Free Trial
Australia 588629 ➤ Try a Free Trial
Australia 6316786 ➤ Try a Free Trial
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Queensland Health
Boehringer Ingelheim
Cerilliant
Farmers Insurance
US Department of Justice
AstraZeneca
Covington
US Army
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.